Lung cancer screening from the oncologist’s perspectiveHow does lung cancer treatment benefit from the NELSON trial

被引：0
作者：
Florian Kocher
Georg Pall
机构：
[1] Medical University of Innsbruck,Department of Internal Medicine V (Hematology and Oncology)
[2] ITOG-Innsbruck Thoracic Oncology Group,undefined
来源：
memo - Magazine of European Medical Oncology | 2019年 / 12卷
关键词：
Lung cancer; Low-dose computed tomography; Screening; Survival; NLST;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
With the release of the survival results from the NELSON lung cancer screening trial there is now additional evidence that low-dose computed tomography (LDCT) screening leads to a reduction of lung cancer mortality in high-risk individuals. These results clearly show that LDCT screening has to be implemented in daily routine. However some questions like the most efficient screening intervals, duration of screening or the most appropriate participant selection are still not finally answered. This article provides a view on lung cancer screening from an oncologist’s perspective.
引用
收藏
页码：175 / 178
页数：3
相关论文
共 79 条
  • [1] Siegel R(2014)Cancer statistics, 2014 Ca: A Cancer J Clin 64 9-29
  • [2] Ma J(2000)Screening for lung cancer N Engl J Med 343 1627-1633
  • [3] Zou Z(2006)Survival of patients with stage I lung cancer detected on CT screening N Engl J Med 355 1763-1771
  • [4] Jemal A(1999)Early Lung Cancer Action Project: overall design and findings from baseline screening Lancet 354 99-105
  • [5] Patz EF(2005)CT screening for lung cancer: five-year prospective experience Radiology 235 259-265
  • [6] Goodman PC(2014)Diagnostic performance of low-dose computed tomography screening for lung cancer over five years J Thorac Oncol 9 935-939
  • [7] Bepler G(2011)Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 395-409
  • [8] Henschke CI(2012)The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups J Thorac Cardiovasc Surg 144 33-38
  • [9] Yankelevitz DF(2018)Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology J Natl Compr Cancer Netw 16 412-441
  • [10] Libby DM(2017)Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 28 iv1-iv21
12345678